Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance

Hong Kong cuts hotel quarantine for travelers to 3 days, plus 4 days of home medical surveillance


Hong Kong is reducing the amount of time travelers will need to serve hotel quarantine, from seven days down to three starting Friday.

“The seven-day quarantine hotel arrangement will be changed to three days in a quarantine hotel, plus four days of home medical surveillance,” Chief Executive John Lee said at a press conference Monday.

After completing the hotel quarantine, travelers can stay at home or in a hotel for the four days of surveillance. During this period people will be able to leave their place of residence, but cannot enter “places where there is active checking of vaccine passes,” Lee said in Cantonese.

That includes bars, pubs, gyms and beauty parlors. People are also not allowed to visit nursing homes, schools and specified medical premises during the surveillance period.

“They cannot participate in any activities where masks are to be taken off,” Lee added. If they test negative on a rapid antigen test, they can take public transportation, go to work and enter shopping malls, he said.

“We have to strike a balance between risk level as well as our economic activity. Where risks could be controlled, we want to preserve maximum movement of people and to maintain Hong Kong’s competitiveness,” Lee said.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More